fluoxetine has been researched along with Colitis, Granulomatous in 3 studies
Fluoxetine: The first highly specific serotonin uptake inhibitor. It is used as an antidepressant and often has a more acceptable side-effects profile than traditional antidepressants.
fluoxetine : A racemate comprising equimolar amounts of (R)- and (S)-fluoxetine. A selective serotonin reuptake inhibitor (SSRI), it is used (generally as the hydrochloride salt) for the treatment of depression (and the depressive phase of bipolar disorder), bullimia nervosa, and obsessive-compulsive disorder.
N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine : An aromatic ether consisting of 4-trifluoromethylphenol in which the hydrogen of the phenolic hydroxy group is replaced by a 3-(methylamino)-1-phenylpropyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| van der Toorn, M | 1 |
| de Klerk, S | 1 |
| Mikocka-Walus, A | 1 |
| Hughes, PA | 1 |
| Bampton, P | 1 |
| Gordon, A | 1 |
| Campaniello, MA | 1 |
| Mavrangelos, C | 1 |
| Stewart, BJ | 1 |
| Esterman, A | 1 |
| Andrews, JM | 1 |
| Dai, C | 1 |
| Jiang, M | 1 |
| Sun, MJ | 1 |
1 trial available for fluoxetine and Colitis, Granulomatous
| Article | Year |
|---|---|
Fluoxetine for Maintenance of Remission and to Improve Quality of Life in Patients with Crohn's Disease: a Pilot Randomized Placebo-Controlled Trial.
Topics: Adult; Antidepressive Agents, Second-Generation; Crohn Disease; Cytokines; Double-Blind Method; Fema | 2017 |
2 other studies available for fluoxetine and Colitis, Granulomatous
| Article | Year |
|---|---|
A 43-year-old woman with a quadriparesis.
Topics: Acidosis; Adult; Atrioventricular Block; Crohn Disease; Female; Fluoxetine; Humans; Hypokalemia; Ile | 2016 |
Fluoxetine for Maintenance of Remission and to Improve Quality of Life in Patients with Crohn's Disease.
Topics: Antibodies, Monoclonal; Crohn Disease; Fluoxetine; Humans; Quality of Life; Remission Induction | 2017 |